The treatment of mixed states and the risk of switching to depression

European Psychiatry

Volumn 20, Issue 2, 2005, Pages 96-100

  Vieta, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Depression; Divalproate; Lamotrigine; Mixed states; Olanzapine; Psychoeducation

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROATE SEMISODIUM; ZIPRASIDONE;

BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; MANIA; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RATING SCALE; REVIEW; RISK FACTOR; SIDE EFFECT;

EID: 15744383413     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.12.002     Document Type: Short Survey

References (21)

1. C.L. Bowden, J.R. Calabrese, G. Sachs, L.N. Yatham, S.A. Asghar, and M. Hompland A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch. Gen. Psychiatry 60 2003 392 400
2. J.R. Calabrese, P.E. Keck, W. Macfadden, M. Minkwitz, T.A. Ketter, and R.H. Weisler A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am. J. Psychiatry 2005 [in press]
3. A. Ciapparelli, L. Dell'Osso, A. Tundo, S. Pini, M.C. Chiavacci, and I. Di Sacco Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression J. Clin. Psychiatry 62 2001 552 555
4. F. Colom, E. Vieta, A. Martinez-Aran, M. Reinares, J.M. Goikolea, and A. Benabarre A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission Arch. Gen. Psychiatry 60 2003 402 407
5. L. Gyulai, C.L. Bowden, S.L. McElroy, J.R. Calabrese, F. Petty, and A.C. Swann Maintenance efficacy of divalproex in the prevention of bipolar depression Neuropsychopharmacology 28 2003 1374 1382
6. R.M. Hirschfeld, P.E. Keck Jr., M. Kramer, K. Karcher, C. Canuso, and M. Eerdekens Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial Am. J. Psychiatry 161 2004 1057 1065
7. R.M. Hirschfeld, J.B. Williams, R.L. Spitzer, J.R. Calabrese, L. Flynn, and P.E. Keck Jr. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire Am. J. Psychiatry 157 2000 1873 1875
8. M.B. Keller, P.W. Lavori, W. Coryell, N.C. Andreasen, J. Endicott, and P.J. Clayton Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness J. Am. Med. Assoc. 255 1986 3138 3142
9. S. Khanna, E. Vieta, B. Lyons, F. Grossman, M. Eerdekens, and M. Kramer Risperidone in the treatment of acute bipolar mania: a double-blind, placebo-controlled study of 290 patients Br. J. Psychiatry 2005 [in press]
10. D.J. Kupfer, E. Frank, Grochocinski, and A.G. Mallinger Stabilization in the treatment of mania, depression and mixed states Acta Neuropsychiatr. 12 2000 110 114
11. A.C. Swann, C.L. Bowden, D. Morris, J.R. Calabrese, F. Petty, and J. Small Depression during mania. Treatment response to lithium or divalproex Arch. Gen. Psychiatry 54 1997 37 42
12. Tohen MF, Greil W, Calabrese JR, Sachs GS, Yatham LN, Müller-Oerlinghausen, et al. Olanzapine versus lithium in relapse/recurrence prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Am J Psychiatry (in press).
13. M. Tohen, R.W. Baker, L.L. Altshuler, C.A. Zarate, T. Suppes, and T.A. Ketter Olanzapine versus divalproex in the treatment of acute mania Am. J. Psychiatry 159 2002 1011 1017
14. M. Tohen, K.N. Chengappa, T. Suppes, R.W. Baker, C.A. Zarate, and C.L. Bowden Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser vs. mood stabiliser alone Br. J. Psychiatry 184 2004 337 345
15. M. Tohen, K.N. Chengappa, T. Suppes, C.A. Zarate Jr., J.R. Calabrese, and C.L. Bowden Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy Arch. Gen. Psychiatry 59 2002 62 69
16. M. Tohen, J.F. Goldberg, A.M. Gonzalez-Pinto Arrillaga, J.M. Azorin, E. Vieta, and M.C. Hardy-Bayle A 12-week, double-blind comparison of olanzapine vs. haloperidol in the treatment of acute mania Arch. Gen. Psychiatry 60 2003 1218 1226
17. M. Tohen, T.G. Jacobs, S.L. Grundy, S.L. McElroy, M.C. Banov, and P.G. Janicak Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group Arch. Gen. Psychiatry 57 2000 841 849
18. M. Tohen, T.M. Sanger, S.L. McElroy, G.D. Tollefson, K.N. Chengappa, and D.G. Daniel Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group Am. J. Psychiatry 156 1999 702 709
19. E. Vieta Bipolar mixed states and their treatment Exp. Rev. Neurother. 5 2005 63 68
20. E. Vieta, and F. Colom Psychological interventions in bipolar disorder: from wishful thinking to an evidence-based approach Acta Psychiatr. Scand. 110 Suppl 422 2004 1 10
21. E. Vieta, J.M. Goikolea, B. Corbella, A. Benabarre, M. Reinares, and G. Martinez Group for the Study of Risperidone in Affective Disorders (GSRAD). Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study J. Clin. Psychiatry 62 2001 818 825